Sales and Marketing

Showing 15 posts of 11526 posts found.

keytruda

FDA approves Merck’s Keytruda for advanced NSC lung cancer

October 5, 2015 Research and Development, Sales and Marketing BMS, NSCL, keytruda, lung cancer, merck sharp and dohme, opdivo

The US Food and Drug Administration has granted accelerated approval for Merck’s Keytruda (pembrolizumab) to treat patients with advanced (metastatic) …
pfizer_hq_new_york

Pfizer completes $130 million purchase of two GSK vaccines

October 5, 2015 Sales and Marketing GSK, Pfizer, meningitis

Pfizer has announced that it has completed the $130 million acquisition of GlaxoSmithKline’s quadrivalent meningococcal ACWY vaccines Nimenrix and Mencevax. …
hilary_clinton

Hillary Clinton takes aim at pharma industry in White House bid

October 5, 2015 Medical Communications, Sales and Marketing turing

Hillary Clinton has taken aim at the pharmaceutical industry with a campaign advert airing in two US states, in which …
sermo

New partnership will speed medical diagnoses through crowdsourcing

October 5, 2015 Medical Communications, Sales and Marketing Global Genes, Sermo

The global social network for physicians, SERMO, is partnering with Global Genes, a leading rare disease patient advocacy organisation, to provide …
karen_bernstein

Dr Karen Bernstein joins Ovid and Vitae boards

October 1, 2015 Medical Communications, Sales and Marketing Dr Karen Bernstein, Ovid Therapeutics, Vitae Pharmaceuticals

Ovid Therapeutics has announced the appointment of Karen Bernstein to the company’s Board of Directors. Dr Bernstein says: “I have …
sayana_press_and_pack

Pfizer’s self-injectable contraceptive becomes UK’s first

September 30, 2015 Medical Communications, Research and Development, Sales and Marketing Pfizer, Syayana Press

Pfizer’s injectable contraceptive, Sayana Press (medroxyprogesterone acetate), is now available to women in the UK for administration by self-injection following …

Roche says Esbriet shown to extend lives of IPF patients

September 30, 2015 Medical Communications, Research and Development, Sales and Marketing Esbriet, Roche, idiopathic pulmonary fibrosis

Roche has presented new clinical data and abstracts on Esbriet (pirfenidone) in the treatment of idiopathic pulmonary fibrosis (IPF), showing …
US flag

Featured market report: US pharmaceutical market to 2018

September 29, 2015 Manufacturing and Production, Sales and Marketing market reports

This report forecasts US pharmaceutical (prescription and over-the-counter) shipments and demand at the manufacturers’ level, to 2018.This industry forecast report …
Soliris

Alexion to challenge Canadian price of Soliris in court

September 28, 2015 Sales and Marketing Alexion, Canada, Drug pricing, Patented Medicine Prices Review Board, eculizumab, soliris

Alexion Pharmaceuticals is taking the Canadian government to court for its attempt to lower the price of the rare disease …
Praluent

Sanofi and Regeneron given European nod for Praluent

September 28, 2015 Sales and Marketing European Commission, Regeneron, Sanofi, alirocumab, high cholesterol, marketing authorisation, praluent

The European Commission (EC) has approved the marketing authorisation of Sanofi and Regeneron’s cholesterol drug Praluent.  The heart drug is …
Novo Nordisk building

FDA approves Novo Nordisk’s diabetes drugs

September 28, 2015 Sales and Marketing FDA, Novo Nordisk, Ryzodeg, Tresiba, diabetes, insulin

The FDA has approved two Novo Nordisk drugs, Tresiba and Ryzodeg, for the treatment of type 2 diabetes in adults.The …
Sanofi reception

Brandicourt set to continue Sanofi restructure

September 28, 2015 Sales and Marketing Merial, Sanofi, olivier brandicourt, restructuring, sales, spin-off

Sanofi chief executive Olivier Brandicourt is considering sales or spin-offs of a number of the company’s divisions, as part of …
law

Legal analysis: compliance top of the agenda for big pharma

September 25, 2015 Medical Communications, Sales and Marketing lawyers, legal, pharma industry, reputation

Do you think big pharma suffers from a negative image, and if so, to what extent do you think this …
abpi_acting_ceo_alison_clough

ABPI responds to UK medicines cost controversy

September 25, 2015 Medical Communications, Sales and Marketing ABPI, Cancer Drugs Fund, NHS

Alison Clough, acting CEO of the Association of the British Pharmaceutical Industry (ABPI), has responded to recent reports in the …
novartis_access_ncds_facts

Novartis launches affordable medicines portfolio for lower-income countries

September 24, 2015 Manufacturing and Production, Sales and Marketing Novartis

Novartis has announced the launch of ‘Novartis Access’, a portfolio of 15 medicines to treat chronic diseases in low and …
The Gateway to Local Adoption Series

Latest content